ID13 - Market scenarios for distributed molecular testing
- Video: Visit Link
- Render Link: https://www.ulissebiomed.com/index.php/en/component/content/article/475-id13-market-scenarios-for-distributed-molecular-testing?catid=2
- Abstract breve: The molecular diagnostics market is shifting from large laboratories to distributed and point-of-care solutions. Significant growth is expected between 2024 and 2030, driven by portable PCR, multiplex testing and cloud/AI integration. Ulisse Biomed, with its Hyris System™ platform (bCUBE™, bAPP™, ambient-stable reagents), is positioning itself as an end-to-end player capable of scaling this revolution.
- Titolo: Market scenarios for distributed molecular testing